Drug Profile
FBF 002
Alternative Names: FBF-002; H7 (FBF-002)Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Fabentech
- Class Influenza A vaccines; Influenza A virus H7N9 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza A virus H7N9 subtype
Most Recent Events
- 12 Sep 2023 Discontinued - Preclinical for Influenza A virus H7N9 subtype in France (IV) (Fabentech pipeline, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Influenza-A virus H7N9 subtype in France (IV)
- 22 Jul 2016 Preclinical trials in Influenza-A virus H7N9 subtype in France (IV)